# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5136536 | T | Inhibition of hERG cardiac ion channel | Homo sapiens | 13 | assay format | Scientific Literature | ||
2. | ALA5136537 | F | Antibacterial activity against cystic fibrosis isolate Staphylococcus aureus by CLSI method | Staphylococcus aureus | 16 | organism-based format | Scientific Literature | ||
3. | ALA5136538 | F | Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method | Staphylococcus aureus | 16 | organism-based format | Scientific Literature | ||
4. | ALA5136539 | F | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by CLSI method | Staphylococcus aureus | 16 | organism-based format | Scientific Literature | ||
5. | ALA5136540 | F | Antibacterial activity against Staphylococcus aureus 3527 by CLSI method | Staphylococcus aureus | 16 | organism-based format | Scientific Literature | ||
6. | ALA5136541 | F | Antibacterial activity against Staphylococcus aureus harbouring GyrA D83N mutant by CLSI method | Staphylococcus aureus | 16 | organism-based format | Scientific Literature | ||
7. | ALA5136542 | B | Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity incubated for 25 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis | Staphylococcus aureus | 15 | protein complex format | Scientific Literature | ||
8. | ALA5136543 | B | Inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity using kDNA as substrate incubated for 10 to 20 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis | Staphylococcus aureus | 15 | protein complex format | Scientific Literature | ||
9. | ALA5136544 | B | Selectivity ratio of IC50 for inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity to IC50 for inhibition of Staphylococcus aureus DNA gyrase supercoiling activity | Staphylococcus aureus | 15 | assay format | Scientific Literature | ||
10. | ALA5136545 | F | Antimicrobial activity against Neisseria gonorrhoeae G strain harbouring type 2 topoisomerase GyrA S91F and ParE G410V mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
11. | ALA5136546 | F | Antimicrobial activity against wild type Neisseria gonorrhoeae ATCC 49226 incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
12. | ALA5136547 | F | Antimicrobial activity against wild type Neisseria gonorrhoeae F strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
13. | ALA5136548 | F | Antimicrobial activity against Neisseria gonorrhoeae K strain harbouring type 2 topoisomerase GyrA S91F, D95N and ParC S87R, S88P mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
14. | ALA5136549 | F | Antimicrobial activity against wild type Neisseria gonorrhoeae O strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
15. | ALA5136550 | F | Antimicrobial activity against wild type Neisseria gonorrhoeae P strain incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
16. | ALA5136551 | F | Antimicrobial activity against wild type Neisseria gonorrhoeae V strain harbouring type 2 topoisomerase GyrA S91F, D95G and ParC S87R mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
17. | ALA5136552 | F | Antimicrobial activity against wild type Neisseria gonorrhoeae Y strain harbouring type 2 topoisomerase GyrA S91F, D95G and ParC S87R mutant incubated for 20 to 24 hrs by CLSI protocol based broth microdilution method | Neisseria gonorrhoeae | 21 | organism-based format | Scientific Literature | ||
18. | ALA5136557 | A | Metabolic stability in mouse liver microsomes assessed as half life | Mus musculus | 13 | microsome format | Scientific Literature | ||
19. | ALA5136559 | T | Cytotoxicity activity against human K562 cells assessed as inhibition of cellular growth | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
20. | ALA5136560 | T | Cytotoxicity activity against human K/VP.5 cells assessed as inhibition of cellular growth | Homo sapiens | 13 | cell-based format | Scientific Literature |